EP Patent

EP1713473B1 — The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd

Assigned to Meda Pharma GmbH and Co KG · Expires 2013-03-13 · 13y expired

What this patent protects

Patent listed against glycopyrronium-tosylate.

Drugs covered by this patent

glycopyrronium-tosylate (GLYCOPYRRONIUM TOSYLATE)

Patent Metadata

Patent number: EP1713473B1
Jurisdiction: EP
Classification: —
Expires: 2013-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Meda Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.